These treatments reduced the frequency of hospitalization, but hematopoietic stem-cell transplantation was nevertheless performed at the age of 2.5 years, due to recurrent severe viral pneumonia attacks and a suspicion that the abnormal immune cell profile resulting from TBK1 deficiency might have contributed to these infections. Here, TBK1 is linked to viral pneumonia.